Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: why not this

why not this

posted on Dec 04, 2007 01:35PM

Infringing companies pay for licensing fee.  JT accumulates cash to 100 million or more.  Invested, this makes at least 8% or 8 million a year.  Using this, JT makes acquisitions.  We become a conglomerate.  We have annual income.  We get listed somewhere better than BB.  If we can dream it, can JT build it?  This could be soooooo sweet.

Share
New Message
Please login to post a reply